Emergent BioSolutions Inc.EBSNYSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR+18.9%
5Y CAGR-21.5%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+18.9%/yr
vs -38.9%/yr prior
5Y CAGR
-21.5%/yr
Recent acceleration
Acceleration
+57.8pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.89 | +83.3% |
| 2024 | 0.49 | +314.6% |
| 2023 | 0.12 | -77.9% |
| 2022 | 0.53 | -59.6% |
| 2021 | 1.31 | -56.2% |
| 2020 | 2.99 | +19.2% |
| 2019 | 2.51 | -33.8% |
| 2018 | 3.80 | +9.6% |
| 2017 | 3.46 | +28.3% |
| 2016 | 2.70 | - |